Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

361 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term results of a prospective, Phase II study of long-term androgen ablation, pelvic radiotherapy, brachytherapy boost, and adjuvant docetaxel in patients with high-risk prostate cancer.
Dibiase SJ, Hussain A, Kataria R, Amin P, Bassi S, Dawson N, Kwok Y. Dibiase SJ, et al. Among authors: kwok y. Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):732-6. doi: 10.1016/j.ijrobp.2010.06.042. Epub 2010 Oct 30. Int J Radiat Oncol Biol Phys. 2011. PMID: 21036486 Clinical Trial.
Long-term follow-up of a prospective trial of trimodality therapy of weekly paclitaxel, radiation, and androgen deprivation in high-risk prostate cancer with or without prior prostatectomy.
Hussain A, Wu Y, Mirmiran A, DiBiase S, Goloubeva O, Bridges B, Mannuel H, Engstrom C, Dawson N, Amin P, Kwok Y. Hussain A, et al. Among authors: kwok y. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):167-74. doi: 10.1016/j.ijrobp.2010.09.009. Epub 2010 Oct 30. Int J Radiat Oncol Biol Phys. 2012. PMID: 21036487 Clinical Trial.
A Phase II Study Evaluating Bone Marrow-Sparing, Image-guided Pelvic Intensity-Modulated Radiotherapy (IMRT) With Cesium-131 Brachytherapy Boost, Adjuvant Chemotherapy, and Long-Term Hormonal Ablation in Patients With High Risk, Nonmetastatic Prostate Cancer.
Rice SR, Olexa G, Hussain A, Mannuel H, Naslund MJ, Amin P, Kwok Y. Rice SR, et al. Among authors: kwok y. Am J Clin Oncol. 2019 Mar;42(3):285-291. doi: 10.1097/COC.0000000000000520. Am J Clin Oncol. 2019. PMID: 30676332 Free PMC article. Clinical Trial.
361 results